News
The January 2020 Journal of Pharmaceutical Sciences issue was dedicated to Carpenter, PhD, and Randolph, PhD.
Earlier this month, Assistant Professor Adam Holewinski earned a prestigious Faculty Early Career Development CAREER Award from the National Science Foundation for his proposal, “Understanding Bifunctionality in Organic Electro-oxidation Catalysis.”
Inscripta, a digital genome engineering company spun out of CU Boulder research, has just raised another $125 million in a Series D financing on the heels of launching its revolutionary product, The Onyx™. Inscripta is having a record funding year, also closing on $105 million in financing in late 2018 and early 2019. The company has raised $259.6 million in total and these new funds will help accelerate the expansion and commercialization of The Onyx™ .
Graduates of the College of Engineering and Applied Science met in Houston to reconnect and hear from Professor Emeritus David Clough.
New research from Professor Robert Garcea of the BioFrontiers Institute and Gillespie Professor Theodore Randolph of the Department of Chemical and Biological Engineering is showing encouraging results in stabilizing vaccines and circumventing the refrigeration requirement, earning an additional $1.2 million in grant funding from the Bill and Melinda Gates Foundation.
A new paper in Nature Energy addresses stability challenges in stacked perovskite solar cells.
Heinz is leading two research projects that received NSF grants in September.
Over the past year, the Department of Chemical and Biological Engineering at CU Boulder has recruited a combination of established and up-and-coming faculty, bringing both experience and fresh perspectives to key research areas.
CU Boulder is part of a new, $100 million interdisciplinary partnership to address critical water security issues in the United States over the next five years, the U.S. Department of Energy announced Monday.
CU Boulder engineers and faculty from the Consortium for Fibrosis Research & Translation (CFReT) at the CU Anschutz Medical Campus have teamed up to develop biomaterial-based “mimics” of heart tissues to measure patients’ responses to an aortic valve replacement procedure, offering new insight into the ways that cardiac tissue re-shapes itself post-surgery.